Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.
about
Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells.Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells.
P2860
Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Phase I trial of subcutaneous ...... n with malignant solid tumors.
@en
type
label
Phase I trial of subcutaneous ...... n with malignant solid tumors.
@en
prefLabel
Phase I trial of subcutaneous ...... n with malignant solid tumors.
@en
P2093
P2860
P1476
Phase I trial of subcutaneous ...... n with malignant solid tumors.
@en
P2093
Fairclough D
Garrison L
P2860
P304
P356
10.1002/(SICI)1096-911X(199706)28:6<444::AID-MPO10>3.0.CO;2-9
P577
1997-06-01T00:00:00Z